These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 14914748)
1. The familial nature of the amino-aciduria of Wilson's disease (hepatolenticular degeneration). UZMAN LL; HOOD B Am J Med Sci; 1952 Apr; 223(4):392-400. PubMed ID: 14914748 [No Abstract] [Full Text] [Related]
2. Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria. BEARN AG; KUNKEL HG J Clin Invest; 1954 Mar; 33(3):400-9. PubMed ID: 13143088 [No Abstract] [Full Text] [Related]
3. Contribution to study of Wilson's disease. GILSANZ V; SEGOVIA JM; CASTRO MENDOZA H AMA Arch Intern Med; 1955 May; 95(5):727-34. PubMed ID: 14360851 [No Abstract] [Full Text] [Related]
4. Amino-aciduria and copper metabolism in hepatolenticular degeneration. SPILLANE JD; KEYSER JW; PARKER RA J Clin Pathol; 1952 Feb; 5(1):16-24. PubMed ID: 14917766 [No Abstract] [Full Text] [Related]
5. On the relationship of urinary copper excretion to the aminoaciduria in Wilson's disease (hepatolenticular degeneration). UZMAN LL Am J Med Sci; 1953 Dec; 226(6):645-52. PubMed ID: 13104417 [No Abstract] [Full Text] [Related]
6. The amino acid content of the blood and urine in Wilson's disease. STEIN WH; BEARN AG; MOORE S J Clin Invest; 1954 Mar; 33(3):410-9. PubMed ID: 13143089 [No Abstract] [Full Text] [Related]
9. [Current views on the pathogenesis of Wilson's disease]. Szeliga J Pediatr Pol; 1973 Mar; 48(3):381-4. PubMed ID: 4571542 [No Abstract] [Full Text] [Related]
10. Wilson's disease in India. II. Biochemical and pathogenetic considerations in patients, parents, and siblings. Manghani DK; Dastur DK Neurology; 1968 Feb; 18(2):117-26. PubMed ID: 5688753 [No Abstract] [Full Text] [Related]
12. The mechanism of copper deposition in the liver in hepatolenticular degeneration (Wilson's disease). UZMAN LL; IBER FL; CHALMERS TC Am J Med Sci; 1956 May; 231(5):511-8. PubMed ID: 13313537 [No Abstract] [Full Text] [Related]
14. [Amino-aciduria with reference to metabolic disorders in hepatolenticular diseases; morbus Wilson and pseudosclerosis]. BLAHA H; GASTAGER H; TSCHABITSCHER H; WEWALKA F Wien Klin Wochenschr; 1954 Dec; 66(48):915-8. PubMed ID: 14359877 [No Abstract] [Full Text] [Related]
15. [Aspects of chemical pathology in 2 cases of Wilson's disease]. Alloro L; Pecorari T Riv Sper Freniatr Med Leg Alien Ment; 1968 Oct; 92(5):1381-401. PubMed ID: 5738558 [No Abstract] [Full Text] [Related]
16. The effect of chelation therapy on the amino aciduria and peptiduria of Wilson's disease. Asatoor AM; Milne MD; Walshe JM J R Coll Physicians Lond; 1983 Apr; 17(2):122-5. PubMed ID: 6842414 [TBL] [Abstract][Full Text] [Related]
17. Comparative metabolism of copper and zinc in patients with Wilson's disease (hepatolenticular degeneration). McCall JT; Goldstein NP; Randall RV; Gross JB Am J Med Sci; 1967 Jul; 254(1):13-23. PubMed ID: 6027683 [No Abstract] [Full Text] [Related]